These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 709394)

  • 1. [Long-term treatment of hypertension with a beta blocking agent (sotalol) alone or in combination with a saluretic agent].
    Verniory A; Staroukine M; Delwiche F
    Brux Med; 1978 Nov; 58(11):569-78. PubMed ID: 709394
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypertension with Sotalol (author's transl)].
    Fillastre JP; Godin M; Joire JE; Gauthier A
    Sem Hop; 1979 Nov 18-25; 55(39-40):1825-31. PubMed ID: 232780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once daily sotalol in the treatment of hypertension.
    Shaw HL
    J R Coll Gen Pract; 1977 Dec; 27(185):742-5. PubMed ID: 616864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic changes after long-term treatment with sotalol in hypertensive patients.
    Castro M; Descamps R; Thomis JA
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):88-91. PubMed ID: 7061183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of arterial hypertension with sotalol, a beta-blocker (author's transl)].
    Klein G; Schnelle K; Schinz A; Oberländer V
    Dtsch Med Wochenschr; 1977 Apr; 102(15):563-9. PubMed ID: 849711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
    G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral sotalol in suppression of premature ventricular complexes and analysis of its beta-adrenergic blocking activity.
    Giorgi C; Nadeau R; Agha A; Primeau R; de Champlain J
    Can J Cardiol; 1990 Jun; 6(5):191-7. PubMed ID: 1696514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of metolazone in the long-term treatment of essential hypertension.
    Cangiano JL; Campos JA; Trevino A; Ramirez-Gonzalez R; Ramirez-Muzo O
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):778-85. PubMed ID: 4217244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects on long-term treatment with indapamide in subjects with essential arterial hypertension].
    Aguglia F; Santucci A; Cicconetti P; Ficara C; Costanzi S
    Clin Ter; 1981 May; 97(4):405-10. PubMed ID: 7018821
    [No Abstract]   [Full Text] [Related]  

  • 11. Sotalol and bethanidine-an open general practice study in the combination therapy of hypertension.
    Rowlands G; McConachie NA; Currie WJ
    Br J Clin Pract; 1977 May; 31(5):57-9. PubMed ID: 884041
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of sotalol and propranolol in mild to moderate essential hypertension.
    Pessina AC; Hlede M; Morandin F; Casiglia E; Gava R; Agnoletto V; Locatelli C; Dal Palu C
    Int J Clin Pharmacol Res; 1983; 3(1):41-5. PubMed ID: 6679506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term management of arterial hypertension using a beta-adrenolytic agent in combination with a saluretic].
    Fryda-Kaurimsky Z; Krüger K; Krüger K
    Med Welt; 1979 Apr; 30(15):572-5. PubMed ID: 449649
    [No Abstract]   [Full Text] [Related]  

  • 14. [Potassium and glucose balance in long-term therapy of hypertension with saluretics].
    Jahnecke J
    Dtsch Med J; 1969 Feb; 20(3):90-3. PubMed ID: 5778531
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical results of the combined use of a diuretic and a beta-blocking agent in the therapy of arterial hypertension].
    Allegri M; Magni S; Freggiaro V; Stirace T
    Clin Ter; 1982 Jan; 100(1):11-9. PubMed ID: 7151366
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phase IV study of an adrenergic beta-blocker].
    Duchéne-Marullaz P
    Therapie; 1983; 38(4):363-70. PubMed ID: 6359565
    [No Abstract]   [Full Text] [Related]  

  • 17. [Graduated plan for the treatment of hypertension].
    Zilcher H; Weber H; Polterauer P; Zasmeta H
    Med Klin; 1981 Sep; 76(20):568-9. PubMed ID: 6124874
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antihypertensive therapy with a single daily dose of sotalol].
    Salvador M; Guittard J; Chamontin B
    Sem Hop; 1982 Nov; 58(43):2519-25. PubMed ID: 6297044
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renin-angiotensin-aldosterone system in the treatment of essential hypertension with a beta-adrenergic blocker: sotalol].
    Psadas C; Sánchez G; Zaldívar HM; Rangel J; Cuéllar A; Serrano PA
    Arch Inst Cardiol Mex; 1977; 47(2):160-70. PubMed ID: 901052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.